US Stock MarketDetailed Quotes
MXRX Med-X
- 4.000
- 0.0000.00%
Close Nov 1 16:00 ET
21.49MMarket Cap-3030P/E (TTM)
0.000High0.000Low0Volume0.000Open4.000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)5.37MShares0.00052wk High12.08P/B8.50MFloat Cap0.00052wk Low--Dividend TTM2.13MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
Med-X Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | 30.82%-1.27M | -9.41%-4.88M | -982.32K | -1.84M | -35.07%-4.46M | -3.3M |
| Net income from continuing operations | 22.16%-1.13M | -47.66%-7.34M | ---2.96M | ---1.45M | -40.36%-4.97M | ---3.54M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---319.61K | ---- |
| Depreciation and amortization | 79.22%10.18K | -27.19%29.04K | --10.42K | --5.68K | -64.67%39.89K | --112.9K |
| Other non cash items | -83.33%1.8K | 78.85%1.91M | --1.89M | --10.78K | 191.66%1.07M | --366.59K |
| Change In working capital | 61.81%-153.81K | 281.61%511.41K | --82.17K | ---402.72K | -17.18%-281.6K | ---240.3K |
| -Change in receivables | 83.39%-17.84K | -130.01%-36.68K | ---9.86K | ---107.43K | 225.46%122.23K | ---97.43K |
| -Change in inventory | 326.14%95.2K | 179.53%162.12K | ---15.3K | ---42.1K | -2,254.85%-203.84K | ---8.66K |
| -Change in prepaid assets | 88.62%-21.93K | 141.42%69.54K | ---33.37K | ---192.8K | -411.24%-167.89K | --53.94K |
| -Change in payables and accrued expense | -246.45%-209.24K | 1,085.69%316.44K | --140.7K | ---60.39K | 82.94%-32.1K | ---188.16K |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | 30.82%-1.27M | -9.41%-4.88M | ---982.32K | ---1.84M | -35.07%-4.46M | ---3.3M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -241.88%-48.71K | 1,004.45%34.33K | -3.8K | |||
| Net PPE purchase and sale | ---- | -241.88%-48.71K | ---- | ---- | 1,004.45%34.33K | ---3.8K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | --0 | -241.88%-48.71K | ---48.71K | --0 | 1,004.45%34.33K | ---3.8K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 12.06%1.27M | -25.20%3.77M | 841.44K | 1.13M | 31.47%5.04M | 3.83M |
| Net issuance payments of debt | -104.98%-3.95K | 770.39%523.99K | --12.57K | --79.41K | -125.48%-78.16K | --306.71K |
| Net common stock issuance | 20.87%1.27M | -36.58%3.25M | --828.87K | --1.05M | 45.12%5.12M | --3.53M |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 12.06%1.27M | -25.20%3.77M | --841.44K | --1.13M | 31.47%5.04M | --3.83M |
| Net cash flow | ||||||
| Beginning cash position | -84.68%209.47K | 81.62%1.37M | --662.88K | --1.37M | 234.61%752.82K | --224.98K |
| Current changes in cash | 99.82%-1.27K | -288.43%-1.16M | ---189.59K | ---704.4K | 16.41%614.46K | --527.84K |
| End cash Position | -68.59%208.21K | -84.68%209.47K | --473.38K | --662.88K | 81.62%1.37M | --752.82K |
| Free cash flow | 30.82%-1.27M | -10.46%-4.93M | ---1.03M | ---1.84M | -34.96%-4.46M | ---3.31M |
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data